| Biological applications of quantum dots T Jamieson, R Bakhshi, D Petrova, R Pocock, M Imani, AM Seifalian Biomaterials 28 (31), 4717-4732, 2007 | 1381 | 2007 |
| Assessment of the efficacy of therapies following venetoclax discontinuation in CLL reveals BTK inhibition as an effective strategy AR Mato, LE Roeker, R Jacobs, BT Hill, N Lamanna, D Brander, ... Clinical Cancer Research 26 (14), 3589-3596, 2020 | 110 | 2020 |
| Anti-CCR9 chimeric antigen receptor T cells for T-cell acute lymphoblastic leukemia PM Maciocia, PA Wawrzyniecka, NC Maciocia, A Burley, T Karpanasamy, ... Blood, The Journal of the American Society of Hematology 140 (1), 25-37, 2022 | 32 | 2022 |
| Current and emerging therapeutic approaches for T‐cell acute lymphoblastic leukaemia R Pocock, N Farah, SE Richardson, MR Mansour British Journal of Haematology 194 (1), 28-43, 2021 | 21 | 2021 |
| Can somatic GATA2 mutation mimic germ line GATA2 mutation? M Sekhar, R Pocock, D Lowe, C Mitchell, T Marafioti, R Dickinson, ... Blood Advances 2 (8), 904-908, 2018 | 17 | 2018 |
| Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: a UK and Ireland analysis A Rampotas, MR Wilson, O Lomas, N Denny, H Leary, G Ferguson, ... British Journal of Haematology 194 (2), 365-377, 2021 | 13 | 2021 |
| Efficacy of therapies following venetoclax discontinuation in CLL: focus on B-cell receptor signal transduction inhibitors and cellular therapies AR Mato, LE Roeker, TA Eyre, R Jacobs, BT Hill, N Lamanna, ... Blood 134, 502, 2019 | 12 | 2019 |
| Humoral and cellular responses to SARS‐CoV‐2 in patients with B‐cell haematological malignancies improve with successive vaccination CL Pinder, D Jankovic, TA Fox, A Kirkwood, L Enfield, A Alrubayyi, ... British Journal of Haematology 202 (6), 1091-1103, 2023 | 4 | 2023 |
| Association of hypertension and cardiac events in patients with multiple myeloma receiving carfilzomib: practical management recommendations SJ Chavda, R Pocock, S Cheesman, KM Lee, E Dowling, DJB Marks, ... British Journal of Haematology, 2020 | 3 | 2020 |
| Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience R Shotton, R Broadbent, A Alchawaf, MB Mohamed, A Gibb, ... Blood Advances 8 (4), 878-888, 2024 | 2 | 2024 |
| PEACE in the midst of an emergency: a rash not to miss C Stavrou, S Mackenzie, R Pocock, AJ Wilson BMJ Case Reports CP 13 (11), e234642, 2020 | 2 | 2020 |
| IRX3 Oncogene Activation in T-ALL through Enhancer Hijacking Caused By fto Intron 8 Deletions S Rahman, N Farah, J Demeulemeester, J R Costa, G Bloye, D O'Connor, ... Blood 140 (Supplement 1), 1009-1010, 2022 | 1 | 2022 |
| Real world analysis of the incidence and impact of hypertension and cardiac toxicity associated with carfilzomib for patients with multiple myeloma SJ Chavda, R Pocock, S Cheesman, E Dowling, P Verma, M Walker, ... Blood 132, 3255, 2018 | 1 | 2018 |
| Focal Deletions of a Promoter Tether Activate the IRX3 Oncogene in T Cell Acute Lymphoblastic Leukemia S Rahman, G Bloye, N Farah, J Demeulemeester, JR Costa, D O'Connor, ... bioRxiv, 2024.02. 06.579027, 2024 | | 2024 |
| Descriptive study of the haematological management of adult patients with severe respiratory failure receiving venovenous extracorporeal membrane oxygenation O Tavabie, R Pocock, N Barrett, A Retter Critical Care 19 (Suppl 1), P303, 2015 | | 2015 |
| DO LIVER FUNCTION TESTS OR MRI FINDINGS PREDICT COAGULOPATHY IN OBSTRUCTIVE JAUNDICE?: 0784 A Lord, P Pucher, A Tonsi, C Gallagher, R Pocock, G Worley, P Hurley International Journal of Surgery 10 (8), S41, 2012 | | 2012 |
| Investigation of the prevalence of clotting abnormalities in obstructive jaundice: Is vitamin K administration justified?: 0720 A Lord, P Hurley, C Gallagher, R Pocock, G Worley International Journal of Surgery 9 (7), 564, 2011 | | 2011 |
